February 2017 – Wuhan YZY Biophama's another core technology patent is granted by the United States Patent Office. This invention patent describes asymmetric structure of bispecific antibodies target...

Recently, there is a good news in our WuHan YZY biopharmaceutical co.LTD. The application for expanded patented protection which owned hard core patented technology BISPECIFIC ANTIBODY (Pat Nos. US 9...

April 8, 2015 – Wuhan YZY biopharma holds the corner stone laying ceremony for its biopharma manufacturing facility at biolake biopharma industry park of the optical valley in Donghu New Technology D...